© 1993 Oxford University Press
research-article |
Autopsy: Consent, Completion and Communication in Alzheimer's Disease Research
Oxford Project to Investigate Memory and Ageing (OPTIMA), University Department of Clinical Neurology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE
Address correspondence to: Dr K. A. Jobst and E. King
The definitive diagnosis of Alzheimer's disease remains histopathological. To date many published studies have been limited by being based on clinical diagnosis alone, which has a significant false positive rate. In a prospective, longitudinal, clinicopathological study which aims to develop an antemortem diagnostic test for Alzheimer's disease, we have achieved 96% (250/260) consent and 97% (59/61) completion rates. We here describe some of the factors we believe are responsible for these high rates and which may be relevant to other studies requiring autopsy to verify clinical diagnoses.
Received October 2, 1992;
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Jagust, R. Thisted, M.D. Devous Sr., R. Van Heertum, H. Mayberg, K. Jobst, A.D. Smith, and N. Borys SPECT perfusion imaging in the diagnosis of Alzheimer's disease: A clinical-pathologic study Neurology, April 10, 2001; 56(7): 950 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hoffman, K. A. Welsh-Bohmer, M. Hanson, B. Crain, C. Hulette, N. Earl, and R. E. Coleman FDG PET Imaging in Patients with Pathologically Verified Dementia J. Nucl. Med., November 1, 2000; 41(11): 1920 - 1928. [Abstract] [Full Text] [PDF] |
||||

